Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)

Market Cap	3.19B -44.2%
Revenue (ttm)	310.89M -10.6%
Net Income	-25.51M
EPS	-0.21
Shares Out	124.13M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,750,070
Open	26.27
Previous Close	26.34
Day's Range	25.55 - 26.27
52-Week Range	23.24 - 63.51
Beta	0.75
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2026

About SHA:688399

Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. The company offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. It also provides HPV and cervical cancer testing services, respiratory infection detection solution, solutions for infectious diarrhea, and STI detection solution for reproductive tract infections. In addition, the company offers biological technology ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 578
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688399

Financial Performance

In 2025, SHA:688399's revenue was 339.05 million, a decrease of -3.02% compared to the previous year's 349.61 million. Losses were -41.08 million, 1952.2% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 14, 2026

Data Sources Report a data error